Cancer virotherapy volume 1 issn 22560920 interactive pdf version 208 mb. Oncolytic viruses, including live attenuated measles virus mv vaccine strains, have recently been shown as promising therapeutic agents against human malignancies. Side effects may vary according to the type of oncolytic virusand what exactly it targetsand may also be influenced by. Viruses from several families are engineered in dr. Design and application of oncolytic viruses for cancer immunotherapy. However, if we are to stand a chance in this war against cancer. Oncolytic virotherapy is a selective and powerful tool for cancer treatment. Yin j, markert jm and leavenworth jw 2017 modulation of the intratumoral immune landscape by oncolytic herpes simplex virus virotherapy. Virotherapy treatment how it works for mesothelioma. Both these ovs are restricted to intratumoral administration into cancer lesions. The nature of viral delivery, infection, and replication makes oncolytic virotherapy valuable for treating cancer patients, especially those with inoperable tumors. However, oncolytic adenovirus oadbased monotherapeutic clinical trials have resulted in modest outcomes. Oncolytic virus ov therapy is based on selective replication of viruses in cancer cells and their subsequent spread within a tumor without causing damage to. Oncolytic virotherapy is a new strategy to reduce tumor burden through selective virus replication in proliferating cells.
The primary clinical milestone has been completion of accrual in a phase 3 trial of intratumoral herpes simplex virus therapy using talimogene laherparepvec for. Pdf oncolytic virotherapy using herpes simplex virus. Oncolytic virotherapy may be a promising approach to treat tnbc. Coxsackievirus a21 cva21 is a novel intercellular adhesion molecule1 icam1targeted immunotherapeutic virus. Oncolytic virotherapy for the treatment of malignant glioma. Our new yale medicineyale new haven health covid19 call center offers information on how to keep yourself and your family healthy. Current limitations exist, however, for oncolytic virotherapy. Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. Advances in the past two years include preclinical proof of feasibility for a singleshot virotherapy cure, identification of drugs that accelerate intratumoral virus propagation, new strategies to maximize the immunotherapeutic potential of oncolytic virotherapy, and clinical.
Poxvirus oncolytic virotherapy oncomyx therapeutics. Vaccineattenuated strains of measles virusmvis an ideal candidate for oncolytic virotherapy which has an excellent safety record. Pdf oncolytic virotherapy stephen bradley academia. Through technological advancements, we have developed sophisticated weapons to fight off tumor growth and invasion. Identification and characterization of alphavirus m1 as a.
Oncolytic myxvs have been tested in a wide variety of animal tumor models, proving its effectiveness as virotherapy against many types of cancers 14. Oncolytic virotherapy is a promising anticancer strategy, because it can provide a local regional control, or eradication of tumors without crossinterference with standard therapies. Sep 23, 2015 oncolytic virotherapy mechanism of action. This field progressed from earlier observations of accidental viral infections causing remission in many malignancies to virus drugs targeting and killing cancer cells. Developing genetically engineered oncolytic viruses for. It appears you dont have adobe reader or pdf support in this web browser. The potential of replication competent oncolytic viruses rcovs has only recently started to be realized. Oncolytic virotherapy method of lines pde analysis in. Oncolytic adenovirus programmed by synthetic gene circuit for. Il15 as the t cell activating stimulus and a prostaglandin synthesis inhibitor as the antiimmunosuppressant were combined with adoptive transfer of tumorspecific t cells. Design and application of oncolytic viruses for cancer. The role of the innate immune system in oncolytic virotherapy.
Oncolytic viruses have become one of the aglare immunotherapies that have been extensively studied and developed. The approval of the first oncolytic virus ov for the treatment of metastatic melanoma and the recent discovery that the use of oncolytic viruses may enhance. Viruses can be designed with biological specificity to infect. This chapter pertains to a mathematical model for cancer therapy based on the use of viruses, that is, oncolytic virotherapy immunotherapy, immuno. Types of virotherapy include oncolytic virotherapy, viral immunotherapy and viral vectors, which is also called viral gene therapy. Mesenchymal stem cells used as carrier cells of oncolytic. The complexity of the immune responses is a major challenge in current virotherapy. Oncolytic virotherapy 3 injections at a 3d interval started 12 d after injection of renca cells in the renal capsule of balbc mice. Localized oncolytic virotherapy overcomes systemic tumor. Allison4 preexisting lymphocytic infiltration of tumors is associated with.
Oncolytic viruses range in size and complexity from large, doublestranded dna viruses such as vaccinia 190 kilobase kb 17 and hsv1 152 kb 18 to the tiny parvovirus h1 5kb linear, singlestranded dna. The use of vv for oncolytic virotherapy is regarded as very safe and generally only causes mild, flulike symptoms. Oncolytic virotherapy promotes intratumoral t cell. Patil, ivan petrov, joseph cappello, marion adelfinger and aladar a. Oncolytic virotherapy is a new strategy to reduce tumor burden through selective virus replication in rapidly proliferating cells. Immune suppression during oncolytic virotherapy for high. Pdf oncolytic virus therapy is perhaps the next major breakthrough in cancer treatment following the success in immunotherapy using. Oncolytic virotherapy is an emerging treatment modality which uses replication competent viruses to destroy cancers. Jul 10, 2012 oncolytic virotherapy is an emerging treatment modality that uses replicationcompetent viruses to destroy cancers. Oncolytic virotherapy in upper gastrointestinal tract cancers. Oncolytic virus therapy shows benefit in patients with. Oncolytic virotherapy for pancreatic cancer expert. For highrisk disease, hematopoietic stem cell transplant hct can be used. Oncoselectivity in oncolytic viruses against colorectal cancer.
Abstract oncolytic virotherapy ovt is a novel form of immunotherapy using natural or genetically modi. Russell, md, phd, center on demonstrating the value of oncolytic virotherapy as a new modality for the treatment of cancer. Oncolytic virotherapy for cancer treatment international. Engeland this book aims to provide a guide for virologists, translational researchers, and clinicians in the field of cancer research by providing reference protocols and methodologies from vector development through clinical translation. Virotherapy is cancer treatment using a virus to find and destroy cancer cells without harming healthy cells. Oncolytic virotherapy is a relatively new therapeutic modality which seeks to turn the cytolytic ability of replicating viruses against cancerous cells, while sparing nonin vivo cancerous cells. Oncolytic virotherapy is an emerging treatment modality that uses replicationcompetent viruses to destroy cancers. Disabling two viral genes enhances tumor selectivity. These branches utilize three different types of treatment methods. Oncolytic viruses workshop 6 may 11, 2020 stephen j. A first in human phase 1 study of cg0070, a gmcsf expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer. Oncolytic virotherapy the use of oncotropic oncolytic viruses in oncology is called oncolytic virotherapy. Oncolytic viruses that is, viruses that destroy cancer cells, but not normal cells are able to infect, replicate inside of, and kill cancer cells through diverse mechanisms.
Tvecs fda approval was undoubtedly a great milestone for the. Pdf oncolytic virotherapy of canine and feline cancer. Mesenchymal stem cells mscs loaded with oncolytic viruses are presently being investigated as a new modality of advancedmetastatic tumors treatment and enhancement of virotherapy. Oncolytic virotherapy, the concept of treating cancer with viruses, is an important mechanism that provides an emerging opportunity in the struggle against cancer in recent past and nowadays. Learn more about virotherapy today to see if this is the best form of treatment for you or a loved one. Oncolytic viruses and their application to cancer immunotherapy. The viral infection also stimulates the bodys immune system to eliminate the infected cancer cells, potentially causing malignant tumors to shrink. In this study, the oncolytic potential of the attenuated vaccine strain leningrad16 l16 of mv was evaluated in a panel of human metastatic melanoma cell lines.
This form of therapy is now the leading treatment used to delay the spread of mesothelioma. The human pathogen herpes simplex virus hsv has proven particularly amenable for use in oncolytic virotherapy. They include human and canine adenoviruses, canine distemper virus cdv, reovirus and members of the poxvirus family such as vaccinia virus, recombinant canary poxvirus alvac. Following the first description of a virus engineered to replicate selectively in dividing cells almost a decade ago,2 the field of viral therapy for cancer virotherapy. They include the bodys b and t cell responses, innate inflammatory reactions, host range, safety risks involved in using modified viruses as treatments, and the requirement that most currently available oncolytic viruses require local. Concept of oncolytic virotherapy clinical implementation. Oncolytic virotherapy for hematological malignancies.
Oncolytic virotherapy journal of vascular and interventional. The viral therapeutic dynamics is largely determined by the viral burst size, relative innate immune killing rate, and relative innate immunity. The approval of the first oncolytic virus ov for the treatment of metastatic. The concept of virotherapy for the treatment of malignant tumors dates back more than a century and can be divided into replicationcompetent oncolytic viruses and. Given the poor outcomes with standardofcare treatments, novel treatment strategies are needed. Properties of the three best studied family of oncolytic viruses used in clinical trials. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasnt until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. The oad potency could be increased by chemotherapyinduced autophagy, an intracellular degradation system that delivers cytoplasmic constituents to the lysosome. It uses a twopronged mechanism of action against cancer. Malignant glioma is the most common primary brain tumor and carries a grim prognosis, with a median survival of just over 14 months. Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Oncolytic immunotherapy for bladder cancer using coxsackie. Hematological malignancies such as leukemias, lymphomas, multiple myeloma mm, and the myelodysplastic syndromes mdss primarily affect adults and are difficult to treat.
Tvec is an oncolytic virus, a virus that selectively replicates inside and kills cancer cells. A novel oncolytic virotherapy using liveattenuated. Oncolytic virotherapy accessscience from mcgrawhill education. As a clinical setting in which local live biological therapy is already well established, nonmuscle invasive bladder cancer nmibc presents intriguing opportunities for oncolytic virotherapy. Oncolytic virotherapy for canine and feline cancers many wild type or recombinant viruses have been tested as oncolytic agents for treatment of canine or feline cancer. Oncolytic virotherapy means the elimination of malignant cells by viral propagation inside the tumor. A new era in cancer treatment rigvir is the first, not genetically modified, nonpathogenic live virus to be registered as a drug and used by oncologists. This study incorporates the innate immune response into our basic model for virotherapy and investigates how the innate immunity affects the outcome of virotherapy. Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. Pde model for oncolytic virotherapy including the required initial conditions ics and boundary conditions bcs. Oct 22, 2019 improving efficacy of oncolytic virotherapy remains challenging due to difficulty increasing specificity and immune responses against cancer and limited understanding of its population dynamics. Safety and efficacy considerations dictate that an ideal oncolytic agent would discriminate between normal and cancer cells on the basis of common genetic abnormalities in human cancers.
Oncolytic virotherapy of canine and feline cancer by ivaylo gentschev, sadeep s. Oncolytic virotherapy of canine and feline cancer core. Health professionals are available to answer your questions, monday friday, 7 am 7 pm. Modulation of the intratumoral immune landscape by oncolytic.
Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its selfperpetuating nature provides an ideal platform for. The relative safety of hsv coupled with extensive knowledge on how hsv interacts with the host has provided a platform for manipulating hsv to enhance the targeting and killing of. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its selfperpetuating nature provides an ideal. Here, we intend to update the progress made in the last five years and to. Cancer virotherapy 3 cancer virotherapy rigvir rigvir. They have undergone different modifications to enhance tumor selectivity, improve intratumoral replication. Progress in oncolytic virotherapy for the treatment of. By permitting replication and viralinduced cell lysis, multiple successions of viral particle release, infection, and. Oncolytic virotherapy is based on the development of replicationcompetent viruses that have the ability to selectively replicate within and kill tumor cells. Review the oncolytic virotherapy treatment platform for. Oncolytic virotherapy journal of oncolytic virotherapy. However, more effective therapies are urgently needed to minimize dismal outcomes for the thyroid malignant neoplasm.
Oncolytic virotherapy is a new modality of cancer treatment which uses competent. We hypothesized that the intratumoral administration of an oncolytic virus optimized to attract immune cells might favorably change the tumor microenvironment in the injected lesions and. Its ability to evade detection and adapt to various cancer therapies means that it is a moving target that becomes increasingly difficult to attack. Oncolytic virotherapy is an exciting, increasingly recognized discipline in cancer research. Both viral proteins and chimeric fcu1 protein could be detected in tumor tissue 2 d following 1 or 2 injections of virus. Kirchenstein institute of microbiology and virology, riga stradins university. We hypothesized that the combination of a local stimulus for activating tumorspecific t cells and an antiimmunosuppressant would improve treatment of gliomas. Oncolytic virotherapy promotes intratumoral t cell infiltration and improves antipd1 immunotherapy.
However, in the setting of autologous hct, relapse due to contamination of the autograft with cancer cells remains a major challenge. Aug 23, 2018 virotherapy is an emerging branch of medicine which explores the use of viruses to kill cancers. Cancer immunotherapy localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy dmitriy zamarin,1,2,3 rikke b. Russell, md, phd the research interests of stephen j. There is currently one oncolytic virus therapy approved by the fda for the treatment of cancer. The phase 1b trial included a baseline biopsy before initiation of intratumoral talimogene laherparepvec injections, with a first injection of up to 4 ml. As diligent scientists search for powerful oncolytic viruses, the field of virotherapy seems destined to continue to expand. A novel oncolytic virotherapy using liveattenuated poliovirus for soft tissue sarcoma 1 atsumi, s. Oncolytic virotherapy is still ongoing clinical trials 49, 3, and some virusdrug com bos, for example talimogene laherparepvec, have been approved for the. Remission of disseminated cancer after systemic oncolytic.
Oncolytic virotherapy dove press open access publisher. Oncolytic virotherapy with an armed vaccinia virus in an. Recently, arming oncolytic viruses with immunomodulatory molecules has been a major focus in virotherapy. Oncolytic virus therapy cancer research institute cri.
The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. Concept of oncolytic virotherapyclinical implementation. Cancer is a traitorous archenemy that threatens our survival. Collectively, these patients provided heretofore unreported insights into the feasibility and risktobene. Subudhi,4 joon seok park,5,6 mena mansour,7,8 peter palese,7 taha merghoub,1,3 jedd d. Virotherapy is a form of therapy which used genetically or naturally produced viruses to attack cancer cells. Oncolytic virotherapy is a growing treatment modality that uses replicating viruses as selective antineoplastic agents. This particular oncolytic virus is based on herpes simplex virus type 1 and has been modified to include a gene that codes for gmcsf, a protein that stimulates the production of immune cells in the body. Oncolytic virotherapy a novel strategy for cancer therapy. Advances in the past two years include preclinical proof of feasibility for a singleshot virotherapy cure, identification of drugs that. Oncolytic virotherapy is a new modality of cancer treatment which uses competent replicating viruses to destroy cancer cells. Virotherapy is an emerging branch of medicine which explores the use of viruses to kill cancers.
330 777 396 1343 1481 64 261 702 1280 599 1411 978 610 72 1510 1331 385 1448 1031 908 457 1543 1452 201 1021 1611 1407 551 1300 987 904 863 1317 114 570 418 1385 552 1207